We are live on ! Find out more
NNVC icon

NanoViricides
NNVC

35 hedge funds and large institutions have $2.04M invested in NanoViricides in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

9% more capital invested

Capital invested by funds: $1.87M → $2.04M (+$175K)

6% more funds holding

Funds holding: 33 → 35 (+2)

0.58% more ownership

Funds ownership: 8.31% → 8.89% (+0.58%)

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
5
Closed
5
Calls
$63K
Puts
–
Net Calls
+$63K
Net Calls Change
-$64K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$148K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$142K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$78.2K
4
Citadel Advisors
Citadel Advisors
Florida
+$25.1K
5
TPWA
TRUE Private Wealth Advisors
Oregon
+$15K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$135K
2
VF
Virtu Financial
New York
-$69K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$43K
4
XT
XTX Topco
Cayman Islands
-$15.5K
5
BCM
Bridgeway Capital Management
Texas
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$866K +$142K +95,167 +19%
Renaissance Technologies
2
Renaissance Technologies
New York
$301K +$148K +99,100 +89%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$228K +$2.15K +1,433 +0.9%
BlackRock
4
BlackRock
New York
$227K – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$74.7K +$78.2K +52,217 New
State Street
6
State Street
Massachusetts
$59.9K – – –
BCM
7
Bridgeway Capital Management
Texas
$51.5K -$12K -8,000 -18%
UBS Group
8
UBS Group
Switzerland
$38.2K -$135K -90,440 -77%
Northern Trust
9
Northern Trust
Illinois
$34.7K – – –
MAWA
10
Moss Adams Wealth Advisors
Washington
$24.3K +$2.99K +2,000 +13%
Citadel Advisors
11
Citadel Advisors
Florida
$24K +$25.1K +16,761 New
WBG
12
Wharton Business Group
Pennsylvania
$22.5K – – –
XT
13
XTX Topco
Cayman Islands
$15.4K -$15.5K -10,367 -49%
FIA
14
Foundations Investment Advisors
Arizona
$14.3K – – –
TPWA
15
TRUE Private Wealth Advisors
Oregon
$14.3K +$15K +10,000 New
BTD
16
BankPlus Trust Department
Mississippi
$10K – – –
Citigroup
17
Citigroup
New York
$7.53K +$7.88K +5,266 New
Osaic Holdings
18
Osaic Holdings
Arizona
$6.52K +$749 +500 +12%
NS
19
NBC Securities
Alabama
$4.86K – – –
ASN
20
Advisory Services Network
Georgia
$4.29K +$4.49K +3,000 New
Simplex Trading
21
Simplex Trading
Illinois
$3K +$3.16K +2,110 New
Morgan Stanley
22
Morgan Stanley
New York
$2.78K – – –
ADL
23
Asset Dedication LLC
California
$2.07K – – –
Group One Trading
24
Group One Trading
Illinois
$1.46K -$7.13K -4,762 -82%
AWM
25
Activest Wealth Management
Florida
$1.43K – – –
1
2

NNVC Hedge Fund Activity: Q3 2025 in Review

35 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2025, worth a combined $2.04M — up 9.4% from $1.87M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NNVC positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $148K. The largest seller was UBS Group, cutting an estimated $135K.

  • 35 institutional investors held NanoViricides (NNVC) as of Q3 2025, up from 33 in Q2 2025.
  • Funds reported $2.04M of NanoViricides stock for Q3 2025, up 9.4% quarter-over-quarter.
  • 7 funds opened new NanoViricides positions in Q3 2025 and 5 closed out, a net change of +2 holders.
  • The largest NanoViricides buyer in Q3 2025 was Renaissance Technologies, an estimated $148K added.
  • The largest NanoViricides seller in Q3 2025 was UBS Group, an estimated $135K sold.

Based on aggregated 13F filings for Q3 2025.